#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic myelomonocytic leukaemia Synovitis Systemic candida Cystic fibrosis lung Metastases to central nervous system Synovial sarcoma recurrent Pleural mesothelioma Sarcoidosis Obliterative bronchiolitis Pulmonary arterial hypertension Arterial tortuosity syndrome Neonatal alloimmune thrombocytopenia Hormone-dependent prostate cancer Graft versus host disease Nephrotic syndrome More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage II – Treatment Kearns-Sayre syndrome Progressive supranuclear palsy – Trials in Disease Pemphigus – Treatment Aicardi-Goutieres syndrome – Treatment Medulloblastoma – Trials in Disease Primary hyperoxaluria – Diagnostics Methylmalonic acidaemia – Diagnostics Waldenstrom’s macroglobulinaemia – Diagnostics Netherton’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Berubicin Hydrochloride Indometacin Avalotcagene Ontaparvovec Mps-103 Erlotinib Sodium Cromoglicate DCC-3084 Quc398 Triamcinolone Hexacetonide Alrefimotide Aldesleukin Entinostat Gskvx000000014593 MORPHINE Balcinrenone Ly3819469 Sodium Methylphenidate Hydrochloride Festuca Rubra Pollen TRV045 Fidanacogene Elaparvovec More therapies…

    Learn about Your Condition

    Post procedural oedema Nephrolithiasis Nocturia Pharyngeal cancer stage I Notalgia paraesthetica Bacterial prostatitis Cutibacterium acnes infection Rectal neoplasm Alveolar rhabdomyosarcoma Peripheral artery restenosis Pigmentary glaucoma Endometrial adenocarcinoma Thromboangiitis obliterans Dedifferentiated liposarcoma Erythema migrans More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Vemurafenib for Children with BRAF Mutation-Resistant Histiocytosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Erdheim-Chester disease
    • Langerhans cell sarcoma
    • Rosai-Dorfman syndrome
    Investigated Drugs:
    • Vemurafenib
    Poland

  • Study of Tislelizumab immunotherapy in patients with liver cancer (hepatocellular carcinoma) who have moderately impaired liver function (Child-Pugh B)

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Tislelizumab
    France

  • Study on Stopping Dimethyl Fumarate and Drug Combination in Patients Aged 55+ with Inactive Relapsing-Remitting Multiple Sclerosis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Diroximel Fumarate
    • Interferon Beta-1A
    • Peginterferon Beta-1A
    France

  • Study on Obinutuzumab for Adolescents with Active Lupus Nephritis and Safety in Children Aged 5 to 12

    Recruiting

    2 1 1
    Investigated Diseases:
    • Lupus nephritis
    Investigated Drugs:
    • Mycophenolate Mofetil
    • Obinutuzumab
    France Italy Poland Spain

  • Study on the Effects of Potassium Canrenoate and Trometamol on Blood Flow in Brain-Dead Organ Donors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Organ donor
    Investigated Drugs:
    • Potassium Canrenoate
    • Trometamol
    • Sodium Chloride
    France

  • Study on the Safety of Encorafenib, Binimetinib, and Ribociclib for Patients with Solid Tumors

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Binimetinib
    • Encorafenib
    • Vemurafenib
    Czechia France Germany Greece Hungary Italy +4
Previous Page
1 … 351 352 353 354 355 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!